Baoquan Liu

Prof. Dr. Baoquan Liu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2017 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
KYKai You
Kai You
FSFei Su
Fei Su
LLLihua Liu
Lihua Liu
XLXiaohong Lv
Xiaohong Lv
JZJianguo Zhang
Jianguo Zhang
BLBaoquan Liu
Baoquan Liu

1 December 2016 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
FSFei Su
Fei Su
XLXuemei Li
Xuemei Li
KYKai You
Kai You
MCMingwei Chen
Mingwei Chen
JXJianbing Xiao
Jianbing Xiao
BLBaoquan Liu
Baoquan Liu

24 October 2022 in Genes
Verified
Journal Article
Open access
PDF file
FSFei Su
Fei Su
ZGZuri Gao
Zuri Gao
YLYueyang Liu
Yueyang Liu
GZGuiqin Zhou
Guiqin Zhou
YCying cui
ying cui
YZYafang Zhang
Yafang Zhang
We aimed to identify miRNAs that were closely related to breast cancer (BRCA). By integrating several methods including significance analysis of microarrays, fold change, Pearson’s correlation analysis, t test, and receiver operating characteristic analysis, we developed a decision-tree-based scoring algorithm, called Optimized Scoring Mechanism for Primary Synergy MicroRNAs (O-PSM). Five synergy miRNAs (hsa-miR-139-5p, hsa-miR-331-3p, hsa-miR-342-5p, hsa-miR-486-5p, and hsa-miR-654-3p) were identified using O-PSM, which were used to distinguish normal samples from pathological ones, and showed good results in blood data and in multiple sets of tissue data. These five miRNAs showed accurate categorization efficiency in BRCA typing and staging and had better categorization efficiency than experimentally verified miRNAs. In the Protein-Protein Interaction (PPI) network, the target genes of hsa-miR-342-5p have the most regulatory relationships, which regulate carcinogenesis proliferation and metastasis by regulating Glycosaminoglycan biosynthesis and the Rap1 signaling pathway. Moreover, hsa-miR-342-5p showed potential clinical application in survival analysis. We also used O-PSM to generate an R package uploaded on github (SuFei-lab/OPSM accessed on 22 October 2021). We believe that miRNAs included in O-PSM could have clinical implications for diagnosis, prognostic stratification and treatment of BRCA, proposing potential significant biomarkers that could be utilized to design personalized treatment plans in BRCA patients in the future.

6 October 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
FSFei Su
Fei Su
ZGZiyu Gao
Ziyu Gao
YLYueyang Liu
Yueyang Liu
GZGuiqin Zhou
Guiqin Zhou
WGWei Gao
Wei Gao
BLBaoquan Liu
Baoquan Liu
Biliary tract cancer (BTC) is a highly aggressive malignant tumor. Serum microRNAs (ser-miRNAs) serve as noninvasive biomarkers to identify high risk individuals, thereby facilitating the design of precision therapies. The study is to prioritize key synergistic ser-miRNAs for the diagnosis of early BTC. Sampling technology, significant analysis of microarrays, Pearson Correlation Coefficients, t-test, decision tree, and entropy weight were integrated to develop a global optimization algorithm of decision forest. The source code is available at https://github.com/SuFei-lab/GOADF.git. Four key synergistic ser-miRNAs were prioritized and the synergistic classification performance was better than the single miRNA’ s. In the internal feature evaluation dataset, the area under the receiver operating characteristic curve (AUC) for each single miRNA was 0.8413 (hsa-let-7c-5p), 0.7143 (hsa-miR-16-5p), 0.8571 (hsa-miR-17-5p), and 0.9365 (hsa-miR-26a-5p), respectively, whereas the synergistic AUC value increased to 1.0000. In the internal test dataset, the single AUC was 0.6500, 0.5125, 0.6750, and 0.7500, whereas the synergistic AUC increased to 0.8375. In the independent test dataset, the single AUC was 0.7280, 0.8313, 0.8957, and 0.8303, and the synergistic AUC was 0.9110 for discriminating between BTC patients and healthy controls. The AUC for discriminating BTC from pancreatic cancer was 0.9000. Hsa-miR-26a-5p was a predictor of prognosis, patients with high expression had shorter survival than those with low expression. In conclusion, hsa-let-7c-5p, hsa-miR-16-5p, hsa-miR-17-5p, and hsa-miR-26a-5p may act as key synergistic biomarkers and provide important molecular mechanisms that contribute to pathogenesis of BTC.

9 November 2023 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
FSFei Su
Fei Su
YLYueyang Liu
Yueyang Liu
YZYonghua Zong
Yonghua Zong
ZGZiyu Gao
Ziyu Gao
GZGuiqin Zhou
Guiqin Zhou
BLBaoquan Liu
Baoquan Liu